TITLE

Medicare list expands

PUB. DATE
June 2009
SOURCE
Marketing Health Services;Summer2009, Vol. 29 Issue 2, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the number of hospital treatments that were considered by Medicare health insurance as treatments that is not covered by its policy in 2009 in the U.S. The treatments excluded from Medicare's coverage are blood clots after knee surgery and surgical site infections after elective surgeries, including bariatric surgery. It cites that preventable errors are included in the original list of Medicare's health coverage.
ACCESSION #
42989620

 

Related Articles

  • Cost-of-illness study of severe haemophilia A and B in five French haemophilia treatment centres. Edgar Tissot; Albert Faradji; Karine Demesmay; Marie Bertrand; Jean-Louis Lorenzini; Marie-Elisabeth Briquel; Patricia Pouzol // Pharmacy World & Science;Jun2008, Vol. 30 Issue 3, p287 

    Abstract   Objective The aim of this study was to assess the consumption of anti-haemophilic drugs by adults and children with severe haemophilia A or B (residual activity of FVIII or FIX ≤2%) and to quantify the average direct medical costs. Method A retrospective multicentre...

  • Putting the news in context. Tosh, Mark // Medical Marketing & Media;Jan2004, Vol. 39 Issue 1, p6 

    Provides information concerning the Medicare industry in the U.S. Medicare drug law recently signed by U.S. President George W. Bush; Impact of the legislation on the entire industry; Advice on how to maintain operating profits at the levels investor have come to expect.

  • on fiscal wake-up tours and toothless tigers. Wilensky, Gail R. // hfm (Healthcare Financial Management);Jun2008, Vol. 62 Issue 6, p38 

    The article reflects on the U.S. Medicare trustees' annual report released in March, 2008. The Part A of trust fund reportedly will be depleted of funds by 2019. It informs that Part B and Part D of Medicare fund cannot be depleted as it is funded by the U.S. Treasury, but it opines that they...

  • Prescription Drugs: Increasing Medicare Beneficiary Access and Related Implications: T-HEHS/AIMD-00-100. Scanlon, William J. // GAO Reports;2/16/2000, p1 

    Focuses on increasing of Medicare and beneficiary access to prescription drugs in the U.S. Gaps in the Medicare program; Long-term cost measures facing the Medicare program.

  • Ensuring Access to Affordable Drug Coverage in Medicare. Antos, Joseph R. // Health Care Financing Review;Winter2005, Vol. 27 Issue 2, p103 

    The long-awaited outpatient prescription drug benefit in Medicare began January 2006. Despite its importance, the drug benefit is controversial. Instead of paying directly for prescriptions, the program will operate through competing private plans. Although it is too early to assess the full...

  • Retiree Health Benefits at Selected Government Contractors: GAO-03-412R.  // GAO Reports;2/27/2003, p1 

    Since World War II, some employers have voluntarily sponsored postretirement health plans as a benefit to their employees. According to government sources, these health plans constitute the primary source of health coverage for retirees aged 55 to 64 and supplemental coverage for nearly one...

  • Medicare Outpatient Drugs: Program Payments Should Better Reflect Market Prices: GAO-02-531T. Dummit, Laura A. // GAO Reports;3/14/2002, p1 

    In some cases, Medicare pays significantly more for covered outpatient drugs than the actual costs to the physicians and pharmacy suppliers. Attempts to reduce these payments have been met with provider claims that overpayments for the drugs are needed to cover underpayments for administering or...

  • Perspectives one year after implementation of the Medicare Prescription Drug Improvement and Modernization Act: A socratic panel discussion. Brill, Joel V.; Siegel, Jerry; Buffington, Daniel E.; Downs, Christian // American Journal of Health-System Pharmacy;8/1/2007 Supplement, Vol. 64, pS16 

    The article presents a panel discussion on the implementation of the Medicare Prescription Drug Improvement and Modernization Act in the U.S. Several medical professionals and experts discusses their views on various health care aspects that will be affected by the Act's implementation,...

  • Medical Reinsurance Reflects Evolving Health Care Market. Troutman, Mark // National Underwriter / Life & Health Financial Services;11/14/2005 Supplement, Vol. 109, pS-16 

    Reports on the role of the medical reinsurance marketplace in the smooth functioning of the U.S. health care system. Assessment of the movement to higher deductibles and coverage limits; Introduction of new capitation arrangements in addition to established capitation risk-takers; Growth of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics